troxacitabine has been researched along with lamivudine in 2 studies
Studies (troxacitabine) | Trials (troxacitabine) | Recent Studies (post-2010) (troxacitabine) | Studies (lamivudine) | Trials (lamivudine) | Recent Studies (post-2010) (lamivudine) |
---|---|---|---|---|---|
72 | 17 | 2 | 7,025 | 1,425 | 2,177 |
Protein | Taxonomy | troxacitabine (IC50) | lamivudine (IC50) |
---|---|---|---|
Capsid protein | Hepatitis B virus | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Burley, SK; Hazra, S; Konrad, M; Lavie, A; Sabini, E | 1 |
2 other study(ies) available for troxacitabine and lamivudine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase.
Topics: Anti-HIV Agents; Antineoplastic Agents; Crystallography, X-Ray; Cytosine; Deoxycytidine Kinase; Dioxolanes; Humans; Lamivudine; Models, Molecular; Prodrugs; Stereoisomerism; Substrate Specificity | 2007 |